PUNIT DHILLON - 27 Sep 2021 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTHQ)

Role
Director
Signature
/s/ Punit Dhillon
Issuer symbol
ARTHQ
Transactions as of
27 Sep 2021
Net transactions value
$0
Form type
4
Filing time
01 Oct 2021, 08:11:08 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTH Stock Option (right to buy) Award $0 +250,000 $0.000000 250,000 27 Sep 2021 Common Stock 250,000 $0.1028 Direct F1
transaction ARTH Stock Option (right to buy) Award $0 +250,000 $0.000000 250,000 27 Sep 2021 Common Stock 250,000 $0.1028 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

PUNIT DHILLON is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.
F2 The option was granted pursuant to the Plan. 1/3 of the option vested on the grant date and the remainder of the option shall vest equally on each of the first 24 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.